Ha I. Kim

Guri-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Toward a future role for liver biopsy in HCC: literature evidence and survey-based perspectives from Korean experts.

Toward a future role for liver biopsy in HCC: literature evidence and survey-based perspectives from Korean experts.

Journal: Journal of liver cancer

Published: May 04, 2026

LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C.

LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C.

Journal: Radiology

Published: March 25, 2025

Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients.

Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients.

Journal: Scientific reports

Published: February 20, 2025

Updated Network Meta-Analysis of First-Line Systemic Treatments for Advanced HCC: Consistent Role of TACE.

Updated Network Meta-Analysis of First-Line Systemic Treatments for Advanced HCC: Consistent Role of TACE.

Journal: Liver cancer

Published: January 18, 2025

Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer's disease in patients with chronic hepatitis B virus infection.

Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer's disease in patients with chronic hepatitis B virus infection.

Journal: Alzheimer's research & therapy

Published: December 28, 2024

Association of Comorbidity Duration with the Occurrence and Prognosis of Steatotic Liver Disease.

Association of Comorbidity Duration with the Occurrence and Prognosis of Steatotic Liver Disease.

Journal: Digestive diseases and sciences

Published: September 02, 2024

Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis.

Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis.

Journal: Clinical and molecular hepatology

Published: March 29, 2023

Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease.

Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease.

Journal: JHEP reports : innovation in hepatology

Published: August 07, 2022

Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno-oncology: A network meta-analysis of randomized sorafenib-controlled trials.

Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno-oncology: A network meta-analysis of randomized sorafenib-controlled trials.

Journal: Hepatology communications

Published: December 29, 2021

Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance.

Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance.

Journal: PloS one

Published: September 13, 2021

PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma.

PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 05, 2021

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis.

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis.

Journal: Clinical and molecular hepatology

Published: July 15, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026